August 2026
You’ve hit your search limit
Start your free trial to keep exploring full traffic and performance insights.
Get StartedInventiva Pharma Market Share Analysis for August 2026
Daix (France), Long Island City (New York, United States), January 4, 2023 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with non-alcoholic steatohepatitis (“NASH”), mucopolysaccharidoses (“MPS”) and other diseases with significant unmet medical needs, today announced...
Inventiva Pharma (including company regionals)
See more website traffic and engagement information- inventivapharma.com
Inventiva Pharma Revenue up to August 2026 is 5M - 10M
revenue generated by Inventiva Pharma top domains
Inventiva Pharma top domains revenue over 3 years
Revenue for Inventiva Pharma top domains
Total visits to Inventiva Pharma's top domains
Understand Inventiva Pharma market share and potential market reach.
Total visits last 3 months
Subsidiaries Breakdown
Avg. visit duration in Inventiva Pharma's top domains
Analyze Inventiva Pharma engagement metrics.
Average visit duration last 3 months
Subsidiaries Breakdown
Avg. pageviews on Inventiva Pharma's top domains
See how Inventiva Pharma keep users engaged, nurture their interest, and encourage them to take the next step.
Average page views last 3 months
Subsidiaries Breakdown
